Previous 10 | Next 10 |
Boston Scientific press release ( NYSE: BSX ): Q4 Non-GAAP EPS of $0.45 misses by $0.02 . Revenue of $3.24B (+3.5% Y/Y) in-line. Reported net sales of $3.242 billion, representing an increase of 3.7 percent on a reported basis, compared to the company's guidance range of 2...
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022 PR Newswire MARLBOROUGH, Mass. , Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing ...
Summary EXG aims to provide its investors with a high level of income through capital gains and dividends. The fund's portfolio consists of a lot of stocks with very low or non-existent dividend yields, making it highly reliant on capital gains. The portfolio has improved somewhat s...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Boston Scientific Corporation (NYSE: BSX). On November 17, 2020, the Company announced a global ...
Summary Penumbra has benefited from renewed enthusiasm around the company's neuro and peripheral thrombectomy platforms, and the company recently launched the Lightning Flash. Management is making a big bet on computer-aided aspiration for benefits like shorter procedure times and impro...
Boston Scientific said it was targeting 'double digit' EPS growth in 2023, the company said at the JPMorgan Healthcare Conference. Analysts estimate the company to earn $1.93 per share. Boston Scientific also targets 50bps annual margin expansion and "strong" free cash flow. Comments ...
Summary In today's update, we are reviewing the fourth-quarter performance of our Alan Lowenthal trading strategy and are analyzing his most interesting, and as always, well-timed trades. Lowenthal sold both his and his wife's Blackstone shares only days prior to the company announcing ...
Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2022 Results PR Newswire MARLBOROUGH, Mass. , Jan. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in ...
Summary Halvorsen's 13F portfolio value decreased marginally from $21.86B to $21.66B this quarter. The number of positions increased from 82 to 88. Viking Global increased Elevance Health, Visa, and McKesson while decreasing T-Mobile US, Parker Hannifin, and Fortive. They also dropped A...
Boston Scientific ( NYSE: BSX ) to make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec Scientific, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures. The Acotec portfolio also in...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...